IOL Chemicals & Pharmaceuticals Ltd. has reported financial results for the period ended March 31, 2021. The company has reported a total income of Rs1991.28 crore during the 12 months period ended March 31, 2021, as compared to Rs1910.49 crore during the 12 months period ended March 31, 2020.
The company has posted a net profit of Rs.444.56 crore for the 12 months period ended March 31, 2021, as against a net profit of Rs.361.29 crore for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.76.21 for the 12 months period ended March 31, 2021, as compared to Rs.63.38 for the 12 months period ended March 31, 2020.
The Q4 FY20-21 result and a QoQ Comparison gives the reason – The company has reported a total income of Rs 466.59 crore during the period ended March 31, 2021, as compared to Rs 520.82 crore during the period ended December 31, 2020. It has posted a net profit of Rs 75.25 crore for the period ended March 31, 2021, as against a net profit of Rs 114.81 crore for the period ended December 31, 2020.
The company has reported EPS of Rs.12.76 for the period ended March 31, 2021, as compared to Rs.19.54 for the period ended December 31, 2020.
We are still bullish on this counter and recommended it several times. Investors need not worry.
